Argentina’s Ministry of Health has introduced new regulations affecting how patients, caregivers, non-profit organizations, and researchers access and cultivate medical cannabis. This overhaul, formalized through Resolution 1780/2025, updates previous guidelines and enforces stricter eligibility requirements and oversight mechanisms.
Overview of REPROCANN REPROCANN, short for Registro del Programa de Cannabis, is Argentina’s national medical cannabis registry established under Law 27.350 in 2017. This registry allows patients and authorized individuals to legally cultivate cannabis for medical purposes, offering them protection from criminal charges under narcotics laws.
Key Changes in 2025 The new regulations highlight several important changes:
1. Redefined Categories: The regulation categorizes cannabis cultivators into four groups: – Patients (autocultivators): Individuals growing cannabis for their personal medical use. – Third-party cultivators: Individuals authorized to grow for a specific patient. – Civil associations and foundations: Nonprofits allowed to cultivate cannabis for multiple patients. – Research and development projects: Institutions conducting approved scientific research on cannabis.
2. Permit Durations: The duration of cultivation permits has changed: – Patients (autocultivators): Permits are valid for three years. – Third-party cultivators, NGOs, and researchers: Permits are valid for one year. This distinction aims to enhance monitoring and ensure patient safety.
3. Stricter Oversight for Non-Patient Cultivators: Third-party cultivators are limited to growing cannabis for themselves and one additional patient. They must submit regular reports, detailed cultivation plans, and cannot have any drug-related criminal history.
4. Higher Standards for Organizations: Nonprofit organizations and research institutions must: – Clearly define cannabis-related objectives in their bylaws. – Appoint a Medical Director with recognized cannabis training. – Employ a Technical Cultivation Manager. – Implement stringent patient confidentiality and tracking systems. – Submit biannual progress reports and chromatographic results.
5. Mandatory Physician Qualifications: To prescribe cannabis under REPROCANN, physicians must now: – Be registered with Argentina’s National Registry of Health Professionals (REFEPS). – Have formal training in cannabis medicine. – Use digital signatures. – Provide a new mandatory Informed Consent form for each patient.
Implications of the New Regulations While Argentina is one of the few countries in Latin America with a legal framework for home cultivation of cannabis, these new regulations arise from concerns about potential misuse, particularly with third-party growers. The government aims to preserve patient access to medical cannabis while preventing unauthorized commercialization.
Impact on Current Users Existing REPROCANN permit holders are not immediately impacted by these changes. However, all registrants must update their documentation within six months, by November 2025, to align with the new regulations, regardless of their permit expiration date. Non-compliance will result in automatic revocation of permits.
Conclusion Despite limited cannabis exports and a prohibition on recreational use, Argentina’s updated medical cannabis framework is noteworthy for other countries considering similar home cultivation models. The reforms signal a trend towards evidence-based cannabis policies in the region.
English 
Spanish 
German 
Czech